Executive readout · one minute
Call research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
PYXS
$3.75
+9.01%
PYXS
· Pyxis Oncology, Inc.
$3.75
+0.31 (+9.01%)
At close · Sep 2
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year from the date these unaudited condensed consolidated financial statements were issued.”View the 10-Q filed Aug 13, 2026
Market Cap
$286.92M
Shares
83.41M
All earnings calls
Earnings call · FY2026 Q1
Pyxis Oncology, Inc. (PYXS) Q1 2026 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Diluted EPS
-$0.37
Net income
-$23.27M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed May 14, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed May 14, 2026 · complete as-filed document